Globus Medical EBIT

Globus Medical (GMED) currently reports a EBIT of $700M as of September 2026. That compares with $450M in the prior-year period — up 55.6% year over year. That is below the Healthcare sector average of $2T. Use the charts on this page to explore Globus Medical's EBIT history and peer comparisons.

Globus Medical's EBIT increased from $450M to $700M — a 55.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Globus Medical's EBIT of $700M is lower than the Healthcare sector average of $2T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Globus Medical reported $700M in EBIT as of September 2026. That compares with $450M in the prior-year period — up 55.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $700M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $2T. From there, open related valuation or income-statement pages for Globus Medical, and consider following GMED for alerts when major investors trade the stock.